The MD Magazine Rosacea condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


People with Rosacea Have Higher Odds of Alzheimer's Disease
Rosacea patients are at a higher risk of developing Alzheimer’s disease and dementia, according to new research.
Chronic inflammatory skin condition, rosacea, may be linked to Parkinson’s disease through shared pathogenic mechanisms.
Initial treatment with once-daily ivermectin 1% cream (Soolantra/Galderma) resulted in longer remission for patients suffering from moderate-to-severe papulopustular rosacea, compared to the initial treatment with twice daily metronidazole 0.75% cream.
Rosacea has been linked to a significantly increased risk of developing glioma.
The US Food and Drug Administration (FDA) today approved azelaic acid (Finacea Foam/Bayer) 15% for the treatment of inflammatory papules and pustules of mild-to-moderate rosacea.
Calling dermatology the study of the skin only begins to scratch the surface of the field. While environmental factors have been thoroughly looked at, advancements in technology are allowing doctors and researchers to look for deeper issues affecting their patients.
Rosacea affects approximately 16 million people in the United States, and patients often present with a variety of symptoms and need an individualized treatment plan.
Soolantra (ivermectin) Cream, 1% has been approved for the once-daily topical treatment of inflammatory lesions, or bumps and pimples, of rosacea.
The presence of Helicobacter pylori infection in patients with rosacea may exacerbate their skin disease.

Most Popular


$vacMongoViewPlus$ $vAR$